The synthesis and the antimicrobial activity of the substituted aryl amides of 3-arylmethyl-2,4- dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylic acids
Keywords:hydantoin, urea, pyrrolidone, antimicrobial agents
By the interaction of the substituted aryl isocyanates with the series of 3-arylmethyl-1,3,7-triazaspiro[ 4.4]nonane-2,4-diones in the propanol-2 medium the series of the substituted aryl amides of 3-arylmethyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylic acids have been obtained. The structure of the products obtained has been confirmed by the instrumental methods of the analysis, such as 1Н, 13С NMR- and chromato-mass spectrometry. The 1Н NMR-spectra of all of the substances obtained contain the signal of the methylene group of the arylmethyl fragment at 4.5 ppm as a singlet; the number and splitting of the signal in the range of the aromatic protons resonance well corresponds with the substitution in the aromatic part of the molecule; the protons of the NHCO urea fragment with the signal of the NH at position 1 are observed as two singlet signals at 7.4-8.2 and 8.9 ppm. The 13C NMR-spectra of all compounds obtained contain four signals at 35, 45, 54 and 65 ppm of the pyrrolidine cycle of the molecules; three signals of the carbonyl groups carbon atoms are observed at 154, 155 and 174 ppm. The LC-MS spectra of the target compounds contain the peaks of [M+H]+ ions, which masses are in good accordance with the structures proposed. The results of the antimicrobial activity screening show the ability of the compounds synthesized to inhibit the growth of the Candida albicans fungi strain. The gram-positive microorganisms such as the strains of Staphylococcus aureus and Bacillus subtilis are found to be sensitive to the compounds containing the methyl groups as substituents in the arylmethyl fragments of the molecule.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Document M100-S22. Vol. 32, No. 3, CLSI, Wayne, PA, January, 2012.
Coyle M.B. Manual of Antimicrobial Susceptibility Testing. – Washington: American Society for Microbiology, 2005. – P. 236.
Honkinen M., Lahti E., Österback R. et al. // Clin. Microbiol. Infec. – 2012. – Vol. 18, №3. – P. 300-307.
Johnson D.H., Rosenthal A., Nadas A.S. // Am. J. Dis. Child. – 1975. – Vol. 51, №4. – P. 581-588.
Infectious diseases of the fetus and newborn infant / Ed. J.Remington, J.Klein, C.Wilson et al. – Philadelphia: PA: Saunders/Elsevier, 2011. – P. 222-275.
Krolenko K.Yu., Silin O.V., Vlasov S.V. et al. // Chem. Heterocycl. Comp. – 2015. – Vol. 51, №4. –P. 472-477.
Magaldi S., Mata-Essayag S., De Capriles C.H. et al. // Int. J. Infect. Dis. – 2004. – Vol. 8, №1. – P. 39-45.
McFarland J. // J. Am. Med. Assoc. – 1907. – Vol. 49, №14. – P. 1176-1178.
Peltola H., Pääkkönen M. // New Engl. J. Med. – 2014. – Vol. 370, №4. – P. 352-360.
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).